The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Pharmacokinetics and Pharmacodynamics of Antibacterial Agents
Open accessAbstract
The pharmacodynamics of an antimicrobial drug relates its pharmacokinetics to the time course of the antimicrobial effects at the site of the infection. Knowledge of the drug's antimicrobial pharmacodynamic effects (eg, rate and extent of bactericidal action and postantibiotic effect) provides a more rational basis for determination of optimal dosing regimens in terms of the dose and the dosing interval than do the minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) determined in vitro. This article reviews pharmacokinetics, antimicrobial pharmacodynamics, the effect of pharmacodynamics on the emergence of resistant bacterial subpopulations, and the development of pharmacodynamic breakpoints for use in the design of trials of these drugs and in the treatment of infected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Moore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Rybak, M. J., Lomaestro, B. M., Rotscahfer, J. C., Moellering, R. C., Craig, W. A., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · Clinical Infectious Diseases · doi:10.1086/600877 · Cited by 815
Moise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W., & Quintiliani, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.650 · Cited by 641
Pharmacodynamics of Levofloxacin: A New Paradigm for Early Clinical Trials
Preston, S. L. (1998) · JAMA · doi:10.1001/jama.279.2.125 · Cited by 589
Craig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Rybak, M. J., Abate, B. J., Kang, S. L., Ruffing, M. J., Lerner, S. A., & Drusano, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1549 · Cited by 431
Clinical Pharmacokinetics of Vancomycin
Matzke, G. R., Zhanel, G. G., & Guay, D. R. P. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611040-00001 · Cited by 360
Craig, W. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321854 · Cited by 318
Rayner, C. R., Forrest, A., Meagher, A. K., Birmingham, M. C., & Schentag, J. J. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00007 · Cited by 306
Lamer, C., de Beco, V, Soler, P., Calvat, S., Fagon, J. Y., Dombret, M. C., Farinotti, R., Chastre, J., & Gibert, C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.281 · Cited by 297
In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid)
Andes, D., van Ogtrop, M. L., Peng, J., & Craig, W. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3484-3489.2002 · Cited by 278
Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally
Eliopoulos, G. M., Drusano, G. L., Ambrose, P. G., Bhavnani, S. M., Bertino, J. S., Nafziger, A. N., & Louie, A. (2007) · Clinical Infectious Diseases · doi:10.1086/520991 · Cited by 266
LEPPER, M. H. (1951) · A.M.A. Archives of Internal Medicine · doi:10.1001/archinte.1951.03810100073006 · Cited by 254
Drusano, G. L., Preston, S. L., Fowler, C., Corrado, M., Weisinger, B., & Kahn, J. (2004) · The Journal of Infectious Diseases · doi:10.1086/383320 · Cited by 245
Antibiotic Pharmacodynamics in Cerebrospinal Fluid
Lutsar, I., McCracken, Jr., & Friedland, I. R. (1998) · Clinical Infectious Diseases · doi:10.1086/515003 · Cited by 242
Brook, I. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.361 · Cited by 241
The Pharmacodynamics of Aminoglycosides
Lacy, M. K., Nicolau, D. P., Nightingale, & Quintiliani, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514620 · Cited by 231
Pharmacodynamics of Fluoroquinolones
Lode, H., Borner, K., & Koeppe, P. (1998) · Clinical Infectious Diseases · doi:10.1086/514623 · Cited by 220
Petrosillo, N., Ioannidou, E., & Falagas, M. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02061.x · Cited by 213
Stevens, D. L., Van, S., & Bryant, A. E. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1401 · Cited by 211
Intracellular pharmacodynamics of antibiotics
Carryn, S., Chanteux, H., Seral, C., Mingeot-Leclercq, M.-P., Van Bambeke, F., & Tulkens, P. M. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00066-7 · Cited by 201 · cited 1×
“However, drugs may be also actively transported out of cells, so the intracellular concentration reflects a balance between ingoing and outgoing processes.(21,22) Just as with interstitial fluid, local factors within the cell may affect the activity of a drug (eg, pH, enzymatic activity).”
BackgroundPharmacodynamics and dosing of aminoglycosides
Turnidge, J. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00057-6 · Cited by 192
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Poudyal, A., Howden, B. P., Bell, J. M., Gao, W., Owen, R. J., Turnidge, J. D., Nation, R. L., & Li, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn425 · Cited by 185
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Experience with a once-daily dosing program of aminoglycosides in critically ill patients
Buijk, S. L. C. E., Mouton, J. W., Gyssens, I. C., Verbrugh, H. A., & Bruining, H. A. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1313-7 · Cited by 162
Bryan, L. E., & Elzen, H. M. V. D. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.6.928 · Cited by 157
Continuous infusion of β-lactam antibiotics in severe infections: a review of its role
Roberts, J. A., Paratz, J., Paratz, E., Krueger, W. A., & Lipman, J. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.02.002 · Cited by 150
Bergen, P. J., Li, J., Nation, R. L., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm511 · Cited by 140
Carryn, S., Françoise Van Bambeke, A., Mingeot‐Leclercq, M., & Tulkens, P. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2095-2103.2002 · Cited by 132
Pharmacokinetic/pharmacodynamic profile for tigecycline—a new glycylcycline antimicrobial agent
Meagher, A. K., Ambrose, P. G., Grasela, T. H., & Ellis‐Grosse, E. J. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.05.006 · Cited by 129
Pharmacodynamics: Relation to Antimicrobial Resistance
Rybak, M. J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.001 · Cited by 120 · cited 1×
“The likelihood that resistant subpopulations will emerge when using antimicrobial therapy will depend on the propensity for resistance within the population, that is, on the spontaneous mutation rate for antibiotic resistance, the ability of host defenses to control the growth of the resistant subpopulation, and the m…”
BackgroundDrug Administration in Chronic Liver Disease
Westphal, J.-F., & Brogard, J. (1997) · Drug Safety · doi:10.2165/00002018-199717010-00004 · Cited by 118
Meagher, A. K., Passarell, J. A., Cirincione, B. B., Wart, S. A. V., Liolios, K., Babinchak, T., Ellis‐Grosse, E. J., & Ambrose, P. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01084-06 · Cited by 114
Passarell, J. A., Meagher, A. K., Liolios, K., Cirincione, B. B., Wart, S. A. V., Babinchak, T., Ellis‐Grosse, E. J., & Ambrose, P. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00813-07 · Cited by 107
Pharmacodynamics of Macrolides, Azalides, and Streptogramins: Effect on Extracellular Pathogens
Carbón, C. (1998) · Clinical Infectious Diseases · doi:10.1086/514619 · Cited by 106
Françoise Van Bambeke, A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg225 · Cited by 101
Chambers, H. F. “., & Kennedy, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.4.510 · Cited by 96
Chow, A. T., Fowler, C. L., Williams, R. R., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2122-2125.2001 · Cited by 90
Tamai, I., Yamashita, J., Kido, Y., Ohnari, A., Sai, Y., Shima, Y., Naruhashi, K., Koizumi, S., & Tsuji, A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38880-9 · Cited by 83
Clinical pharmacodynamics of quinolones
Ambrose, P. G., Bhavnani, S. M., & Owens, R. C. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00061-8 · Cited by 82
Coagulase-Negative Staphylococcal Adherence and Persistence
Quie, P. G., & Belani, K. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.4.543 · Cited by 78
Jacqueline, C., Batard, É., Grandière-Pérez, L., Boutoille, D., Hamel, A., Caillon, J., Kerguéris, M.-F., Potel, G., & Bugnon, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3706-3711.2002 · Cited by 77
Pharmacodynamics: Relation to antimicrobial resistance
Rybak, M. J. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.227 · Cited by 77
Effect of hepatic insufficiency on pharmacokinetics and drug dosing.
Verbeeck, R. K., & Horsmans, Y. (1998) · Pharmacy World & Science · doi:10.1023/a:1008656930082 · Cited by 76
Chambers, H. F. “., Mills, J. L., Drake, T. A., & Sande, M. A. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_4.s870 · Cited by 73
Ingerman, M. J., Pitsakis, P. G., Rosenberg, A. F., & Levison, M. E. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.4.707 · Cited by 57
Self-citationPharmacodynamics to combat resistance
Woodnutt, G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020890 · Cited by 43
Uptake and Intracellular Activity of Linezolid in Human Phagocytes and Nonphagocytic Cells
Pascual, Á., Ballesta, S., Garcı́a, I., & Perea, E. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.4013-4015.2002 · Cited by 37
Bamberger, D. M., Herndon, B., & Suvarna, R. P. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.4.893 · Cited by 28
Antibiotic Selection and Pharmacokinetics in the Critically Ill
Bush, L. M., & Levison, M. E. (1988) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30494-9 · Cited by 21
Self-citationFalagas, M. E., Bliziotis, I. A., & Rafailidis, P. I. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.03.003 · Cited by 9
Cited by
Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa530 · Cited by 1,662
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
“unwarranted in cases where sustained or heightened plasma concentration is required[102].”
BackgroundThe intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
A comprehensive insight on ocular pharmacokinetics
Agrahari, V., Mandal, A., Agrahari, V., Trinh, H. M., Joseph, M., Ray, A., Hadji, H., Mitra, R., Pal, D., & Mitra, A. K. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0339-2 · Cited by 462
Plasmids, a molecular cornerstone of antimicrobial resistance in the One Health era
Castañeda-Barba, S., Top, E. M., & Stalder, T. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00926-x · Cited by 379
Metadata
- Authors
- Levison, M. E., & Levison, J. H.
- Venue
- Infectious Disease Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 23
- Issue
- 4
- Pages
- 791-815
- ISSN
- 0891-5520 (ISSN-L)
- OpenAlex
- W2019799507
- Cited by
- 557
- References
- 56
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.